dGenThera is a next-generation targeted radiotherapeutics company advancing a differentiated pipeline of theranostic agents optimized for safety, scalability, and precision oncology. dGenThera’s proprietary chemistry enables exquisitely matched theranostic pairs—leveraging Astatine-211 (211At), Iodine-131 (131I), and Fluorine-18 (18F)—with engineered stable carbon-halogen bonds to drive accurate dosimetry, improve patient stratification, and reduce off-target toxicity.
Company Details
- Employees
- 3
- Founded
- 2023
- Address
- Durham, Nc 27701, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.dgenthera.com/
- HQ
- Durham, NC
Dgenthera Questions
Dgenthera's website is https://www.dgenthera.com/
Dgenthera's LinkedIn profile is https://www.linkedin.com/company/dgenthera
Dgenthera has
3 employees.
View email and phone details for 3
employees at Dgenthera.
Dgenthera's industry is
Biotechnology Research
Dgenthera's top competitors are
Radiopharm Theranostics,
Starlight Therapeutics,
Low Institute For Therapeutics,
Biopunk Community Lab,
Asta Bio,
Nusano,
Rlt Angels,
Eradivir,
Elemera Australia,
Trypto Therapeutics.
Dgenthera's categories are Biotechnology Research
Dgenthera's founding year is 2023
